AUTHOR=Bleve Sara , Cursano Maria Concetta , Casadei Chiara , Schepisi Giuseppe , Menna Cecilia , Urbini Milena , Gianni Caterina , De Padova Silvia , Filograna Alessia , Gallà Valentina , Rosti Giovanni , Barone Domenico , Chovanec Michal , Mego Michal , De Giorgi Ugo TITLE=Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer JOURNAL=Frontiers in Oncology VOLUME=12 YEAR=2022 URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.910087 DOI=10.3389/fonc.2022.910087 ISSN=2234-943X ABSTRACT=

Germ cell tumors are the most common malignant tumors in male young adults. Platinum-based chemotherapy has dramatically improved the outcome of metastatic germ cell tumor patients and overall cure rates now exceed 80%. The choice of medical treatment can be guided by the prognosis estimation which is an important step during the decision-making process. IGCCCG classification plays a pivotal role in the management of advanced disease. However, histological and clinical parameters are the available factors that condition the prognosis, but they do not reflect the tumor’s molecular and pathological features and do not predict who will respond to chemotherapy. After first-line chemotherapy 20%-30% of patients relapse and for these patients, the issue of prognostic factors is far more complex. Validated biomarkers and a molecular selection of patients that reflect the pathogenesis are highly needed. The association between cancer-related systemic inflammation, tumorigenesis, and cancer progression has been demonstrated. In the last years, several studies have shown the prognostic utility of immune-inflammation indexes in different tumor types. This review analyzed the prognostic impact of inflammatory markers retrieved from routine blood draws in GCT patients.